Report: Growth Factors: Indications, Products, and Markets TOC

chapter one: Executive Summary

Growth Factor Types

Blood Growth Factors
Erythropoietin
Colony stimulating factors
Cytokines
Tissue Growth Factors
Platelet-derived growth factor
Epidermal growth factor
Transforming growth factor-â
Transforming growth factor-á
Keratocyte growth factor
Insulin-like growth factor-I
Neurturin
Hepatocyte growth factor
Vascular endothelial growth factor
Fibroblast growth factors

Key Established Indications

Blood Growth Factors
Adjunctive Cancer Therapy
Hepatitis C
Condylomata Acuminata
Multiple Sclerosis
Osteopetrosis
Neutropenia
Tissue Growth Factors
Diabetic Foot Ulcers
New Bone Formation
Wound Care
Thrombocytopenia

Key Emerging Indications for Growth Factors

Oral Mucositis
Diabetic Neuropathy
Neurological Disorders
Ophthalmology
Muscle Atrophy
Wound Care
Tissue Growth
Kidney Disease
Orthopedics
Cardiovascular Disease
Bone Disease-Defects-Repair

Major Market Players

Blood Growth Factors
Tissue Growth Factors

Issues Driving the Market

Worldwide Market Forecast Summary

Blood Growth Factors
Tissue Growth Factors

Scope and Methodology

Chapter Two: Introduction

The Need for Growth Factors

Growth Factors Defined

Blood Growth Factors

Erythropoietins
Colony Stimulating Growth Factors
The Interleukins
The Interferons

Tissue Growth Factors

Wound Healing Growth Factors
Platelet Derived Growth Factor
Keratocyte Growth Factor
Epidermal Growth Factor
Vascular Endothelial Growth Factor
Neurotrophic Growth Factors
Fibroblast Growth Factors
Insulin-Like Growth Factor
Musculoskeletal and Connective Tissue Growth Factors

Market Drivers

Population Growing
Potential for Serious Disease Increases
Epidemiologic Data and Demand Analysis
Adjunctive Cancer Therapy
Hepatitis C
Kidney/Renal Disease
Diabetic Neuropathy
Oral Mucositis
Stroke
Parkinson' s Disease
Alzheimer' s Disease
Atrophy
Macular Degeneration
Cardiovascular/Vascular Disease
Thrombocytopenia
Bone Repair
Wound Care
Tissue Engineering

Challenges Facing Developers

Biologics Issues Hurdle
Importance of Process Control

chapter three: Research Trends

In the Pipeline

Specific Research Highlights

Blood Vessel Growth
Blood Vessel Cells
Cartilage Formation
Disease-Fighting Cells
Skin Treatment
Stroke Therapy
Sarcopenia
Parkinson' s Disease

chapter four: The Market

Overall Forecasts and Trends

Products on the Market

Research Products

Market Players and Product Share

Erythropoietins
Colony Stimulating Factors
Interleukins
Interferons
Wound Growth Factors
Neurotrophic Growth Factors

Worldwide Market Forecast for Growth Factors

Established Blood Growth Factor Markets
Erythropoietins
Colony Stimulating Factors
The Interleukins
The Interferons
Established Tissue Growth Factor Markets
Wound Healing Growth Factors
Neurotrophic Growth Factors
Geographical Forecasts

chapter five: Company Profiles

Advanced Tissue Sciences
Amgen Inc.
Anika Therapeutics Inc.
Biomimetic Pharmaceuticals Inc.
Biosurface Engineering Technologies Inc.
Boston Life Sciences Inc.
Ceregene Inc.
Chiron Corp.
CuraGen Corp.
Curis Inc.
Eyetech Pharmaceuticals Inc
FibroGen Inc.
Genentech Inc.
GenSci Regeneration Sciences Inc.
GenVec Inc.
Human Genome Sciences
Insmed Inc.
Johnson & Johnson
Orquest Inc.
Protein Polymer Technology Inc.
Regeneron Pharmaceuticals Inc.
Sangamo BioSciences Inc.
Selective Genetics Inc.
Spectrum Pharmaceuticals Inc.
Stryker Biotech
Theratechnologies
Transition Therapeutics Inc.
Wyethcc.
ZymoGenetics Inc.

Appendix: Company Directory

List of Exhibits

chapter one: Executive Summary

Table 1-1: World Market for Blood Growth Factors by Segment 2003 & 2007
Table 1-2: World Market for Tissue Growth Factors 2003, 2004, 2007

chapter two: Introduction

Table 2-1: World Population Distribution by General Age Group 1996, 2001, 2006, 2025, 2050
Table 2-2: Cancer Incidence and Deaths as a Percentage to Population by Selected Country/Region, 2001
Table 2-3: Global and U.S. Yearly Incidence of Skin Ulcers by Type
Figure 2-1: Global and U.S. Yearly Incidence of Skin Ulcers by Type

chapter three: Research Trends

Table 3-1: Selected Developmental Growth Factor-Based Therapies

chapter four: The Market

Table 4-1: World Market for Growth Factor Therapeutics Blood Growth Factors 2003-2007
Table 4-2: World Market for Growth Factor Therapeutics Tissue Growth Factors 2003-2007
Table 4-3: Growth Factor-Based Therapies on the Market
Table 4-4: Market Share for Leading Growth Factor Therapeutics Erythropoietins 2003
Table 4-5: Market Share for Leading Growth Factor Therapeutics Colony Stimulating Factors 2003
Table 4-6: Market Share for Leading Growth Factor Therapeutics Interleukins 2003
Table 4-7: Market Share for Leading Growth Factor Therapeutics Interferons 2003
Table 4-8: Market Share for Leading Growth Factor Therapeutics Wound Care Growth Factors 2005
Table 4-9: Market Share for Leading Growth Factor Therapeutics Neurotrophic Growth Factors 2005
Table 4-10: Total World Market for Blood Growth Factors 2003-2007
Table 4-11: World Market for Blood Growth Factors Distribution of Revenues by Factor Type 2003-2007
Table 4-12: World Market for Erythropoietins 2003-2007
Table 4-13: World Market for Colony Stimulating Factors 2003-2007
Table 4-14: World Market for Interleukins 2003-2007
Table 4-15: World Market for Interferons 2003-2007
Table 4-16: Total World Market for Tissue Growth Factors 2003-2007
Table 4-17: World Market for Tissue Growth Factors Distribution of Revenues by Factor Type, 2003-2007
Table 4-18: World Market for Wound Growth Factors 2003-2007
Table 4-19: World Market for Neurotrophic Growth Factors 2003-2007
Table 4-20: The Market for Erythropoietins by Geographical Region 2003-2007
Table 4-21: The Market for Colony Stimulating Factors by Geographical Region 2003-2007
Table 4-22: The Market for Interleukins by Geographical Region 2003-2007
Table 4-23: The Market for Interferons by Geographical Region 2003-2007
Table 4-24: The Market for Wound Growth Factors by Geographical Region 2003-2007
Table 4-25: The Market for Neurotrophic Growth Factors by Geographical Region 2003-2007